Close Menu

NEW YORK (360Dx) – Group K Diagnostics said today that it has secured $2 million in Series A funding.

The funding follows a $425,000 angel funding round that the company disclosed in September.

Philadelphia-based GKD said it is developing a microfluidic point-of-care platform called MultiDiagnostic to provide test results in 20 minutes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.